172 related articles for article (PubMed ID: 16709242)
1. Microarray-based identification of antigenic variants of foot-and-mouth disease virus: a bioinformatics quality assessment.
Martín V; Perales C; Abia D; Ortíz AR; Domingo E; Briones C
BMC Genomics; 2006 May; 7():117. PubMed ID: 16709242
[TBL] [Abstract][Full Text] [Related]
2. Foot-and-mouth disease virus lacking the VP1 G-H loop: the mutant spectrum uncovers interactions among antigenic sites for fitness gain.
Baranowski E; Ruiz-Jarabo CM; Lim F; Domingo E
Virology; 2001 Sep; 288(2):192-202. PubMed ID: 11601891
[TBL] [Abstract][Full Text] [Related]
3. Serotype-specific differences in antigenic regions of foot-and-mouth disease virus (FMDV): a comprehensive statistical analysis.
Cooke JN; Westover KM
Infect Genet Evol; 2008 Dec; 8(6):855-63. PubMed ID: 18790086
[TBL] [Abstract][Full Text] [Related]
4. Antigenic site variation in foot-and-mouth disease virus serotype O grown under vaccinal serum antibodies in vitro.
Sarangi LN; Mohapatra JK; Subramaniam S; Sanyal A; Pattnaik B
Virus Res; 2013 Sep; 176(1-2):273-9. PubMed ID: 23850868
[TBL] [Abstract][Full Text] [Related]
5. Microarray-based detection and typing of foot-and-mouth disease virus.
Baxi MK; Baxi S; Clavijo A; Burton KM; Deregt D
Vet J; 2006 Nov; 172(3):473-81. PubMed ID: 16139533
[TBL] [Abstract][Full Text] [Related]
6. Influence of the mutant spectrum in viral evolution: focused selection of antigenic variants in a reconstructed viral quasispecies.
Martín V; Domingo E
Mol Biol Evol; 2008 Aug; 25(8):1544-54. PubMed ID: 18436553
[TBL] [Abstract][Full Text] [Related]
7. DNA vaccination against foot-and-mouth disease via electroporation: study of molecular approaches for enhancing VP1 antigenicity.
Kim SA; Liang CM; Cheng IC; Cheng YC; Chiao MT; Tseng CJ; Lee F; Jong MH; Tao MH; Yang NS; Liang SM
J Gene Med; 2006 Sep; 8(9):1182-91. PubMed ID: 16927362
[TBL] [Abstract][Full Text] [Related]
8. Foot-and-mouth disease virus (FMDV) with a stable FLAG epitope in the VP1 G-H loop as a new tool for studying FMDV pathogenesis.
Lawrence P; Pacheco JM; Uddowla S; Hollister J; Kotecha A; Fry E; Rieder E
Virology; 2013 Feb; 436(1):150-61. PubMed ID: 23228860
[TBL] [Abstract][Full Text] [Related]
9. Vesicular Stomatitis Virus glycoprotein G carrying a tandem dimer of Foot and Mouth Disease Virus antigenic site A can be used as DNA and peptide vaccine for cattle.
Capozzo AV; Wilda M; Bucafusco D; de los Ángeles Lavoria M; Franco-Mahecha OL; Mansilla FC; Pérez-Filgueira DM; Grigera PR
Antiviral Res; 2011 Nov; 92(2):219-27. PubMed ID: 21889542
[TBL] [Abstract][Full Text] [Related]
10. Genetic and antigenic analysis of type A foot-and-mouth disease viruses isolated in India during 1987-1996.
Nayak B; Pattnaik B; Tosh C; Sanyal A; Hemadri D; Patil SS; Venkataramanan R
Acta Virol; 2001 Feb; 45(1):13-21. PubMed ID: 11394573
[TBL] [Abstract][Full Text] [Related]
11. Pan-serotypic detection of foot-and-mouth disease virus by RT linear-after-the-exponential PCR.
Reid SM; Pierce KE; Mistry R; Bharya S; Dukes JP; Volpe C; Wangh LJ; King DP
Mol Cell Probes; 2010 Oct; 24(5):250-5. PubMed ID: 20433917
[TBL] [Abstract][Full Text] [Related]
12. A novel bi-functional DNA vaccine expressing VP1 protein and producing antisense RNA targeted to 5'UTR of foot-and-mouth disease virus can induce both rapid inhibitory effect and specific immune response in mice.
Yang B; Lan X; Li X; Yin X; Li B; Han X; Li Y; Zhang Z; Liu J
Vaccine; 2008 Oct; 26(43):5477-83. PubMed ID: 18694793
[TBL] [Abstract][Full Text] [Related]
13. Evidence of the coevolution of antigenicity and host cell tropism of foot-and-mouth disease virus in vivo.
Tami C; Taboga O; Berinstein A; Núñez JI; Palma EL; Domingo E; Sobrino F; Carrillo E
J Virol; 2003 Jan; 77(2):1219-26. PubMed ID: 12502839
[TBL] [Abstract][Full Text] [Related]
14. Development of one-step multiplex RT-PCR method for simultaneous detection and differentiation of foot-and-mouth disease virus serotypes O, A, and Asia 1 circulating in Vietnam.
Le VP; Lee KN; Nguyen T; Kim SM; Cho IS; Van Quyen D; Khang DD; Park JH
J Virol Methods; 2011 Jul; 175(1):101-8. PubMed ID: 21550367
[TBL] [Abstract][Full Text] [Related]
15. Monitoring sequence space as a test for the target of selection in viruses.
Perales C; Martín V; Ruiz-Jarabo CM; Domingo E
J Mol Biol; 2005 Jan; 345(3):451-9. PubMed ID: 15581890
[TBL] [Abstract][Full Text] [Related]
16. Genomic and antigenic characterization of viruses from the 1993 Italian foot-and-mouth disease outbreak.
Núñez JI; Fusi P; Borrego B; Brocchi E; Pacciarini ML; Sobrino F
Arch Virol; 2006 Jan; 151(1):127-42. PubMed ID: 16096711
[TBL] [Abstract][Full Text] [Related]
17. Selection of antigenic variants of foot-and-mouth disease virus in the absence of antibodies, as revealed by an in situ assay.
Diez J; Mateu MG; Domingo E
J Gen Virol; 1989 Dec; 70 ( Pt 12)():3281-9. PubMed ID: 2481712
[TBL] [Abstract][Full Text] [Related]
18. Development of a novel quantitative real-time RT-PCR assay for the simultaneous detection of all serotypes of foot-and-mouth disease virus.
Rasmussen TB; Uttenthal A; de Stricker K; Belák S; Storgaard T
Arch Virol; 2003 Oct; 148(10):2005-21. PubMed ID: 14551821
[TBL] [Abstract][Full Text] [Related]
19. Duration and fitness dependence of quasispecies memory.
Ruíz-Jarabo CM; Arias A; Molina-París C; Briones C; Baranowski E; Escarmís C; Domingo E
J Mol Biol; 2002 Jan; 315(3):285-96. PubMed ID: 11786012
[TBL] [Abstract][Full Text] [Related]
20. DNA vaccines expressing B and T cell epitopes can protect mice from FMDV infection in the absence of specific humoral responses.
Borrego B; Fernandez-Pacheco P; Ganges L; Domenech N; Fernandez-Borges N; Sobrino F; Rodríguez F
Vaccine; 2006 May; 24(18):3889-99. PubMed ID: 16563575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
